As of Thursday close, HCA Healthcare Inc.’s (NYSE:HCA) stock was down -$0.77, moving down -0.30 percent to $253.44. The average number of shares traded per day over the past five days has been 1,825,080 shares. 1 time new highs have been achieved over the past 5 days, with a -$10.14 fall in that time frame. In the last twenty days, the average volume was 1,202,235, while in the previous 50 days, it was 1,327,572.
Since last month, HCA stock retreated -7.78%. Shares of the company fell to $252.32 on 09/15/23, the lowest level in the past month. A 52-week high of $304.86 was reached on 06/30/23 after having rallying from a 52-week low of $178.32. Since the beginning of this year, HCA’s stock price has risen by 5.62% or $13.48, and marked a new high 21 times. However, the stock has declined by -16.87% since its 52-week high.
HCA stock investors should be aware that HCA Healthcare Inc. (HCA) stock had its last reported insider trading activity 39 days ago on Aug 14. Torres Kathryn A., the SVP-Payer Contracting & Align. of the company, disposed of 5,204 shares for $269.12 on Aug 14. It resulted in a $1,400,516 divestment by the insider. Cohen Jeffrey E. sold 1,500 shares at an average price of $270.00 on Aug 11. The insider now owns 4,414 shares following the transaction. On Aug 03, SVP & Chief Ethics Officer Whalen Kathleen M sold 2,916 shares at $270.00 apiece. The transaction was valued at $787,320.
Valuation Metrics
Right now, HCA Healthcare Inc. (HCA) has a P/E ratio of about 12.46. The stock’s beta is 1.62.
The latest dividend of $0.60 per share was paid out, remained unchanged from last year’s $0.60. On Friday January 27 2023, a $0.04 dividend increase was announced.
Financial Health
In the three months ended June 29, HCA Healthcare Inc.’s quick ratio stood at 1.00, while its current ratio was 1.20, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 84.40% percent. In the year ended June 29, EBITDA margin amounted to 19.96%, whereas operating margins totaled 15.00%. Based on annual data, HCA earned $50.86 billion in gross profit and brought in $60.23 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 20.50%. Return on equity (ROE) for the past 12 months was -211.10%.
In HCA Healthcare Inc.’s quarter-end financial report for June 29, it reported total debt of $36.54 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. HCA’s revenue rose 6.56% to $15.59 billion during the quarter, while net income inched up to $15.86 billion. While analysts expected HCA Healthcare Inc. to report $4.22 quarterly earnings, the actual figure was $4.29 per share, beating the consensus estimate by 1.70%. During the quarter, the company generated $3.06 billion in EBITDA. The liabilities of HCA Healthcare Inc. were 53.13 billion at the end of its most recent quarter ended June 29, and its total debt was $40.74 billion. The value of shareholders’ equity is $271.99 million.
Technical Picture
This quick technical analysis looks at HCA Healthcare Inc.’s (HCA) price momentum. With a historical volatility rate of 23.54%, the RSI 9-day stood at 23.32% on 21 September.
With respect to its five-day moving average, the current HCA Healthcare Inc. price is down by -3.85% percent or -$10.14. At present, HCA shares trade -8.56% below its 20-day simple moving average and -11.79% percent below its 100-day simple moving average. However, the stock is currently trading approximately -14.16% below its SMA50 and +6.03% above its SMA200.
Stochastic coefficient K was 5.73% and Stochastic coefficient D was 8.18%, while ATR was 4.73. Given the Stochastic reading of 3.91% for the 14-day period, the RSI (14) reading has been calculated as 28.98%. As of today, the MACD Oscillator reading stands at -5.28, while the 14-day reading stands at -10.91.
Analyst Ratings
Cantor Fitzgerald launched its rating on HCA Healthcare Inc. (NYSE: HCA) to an Overweight in a note to investors on April 21, 2023. HCA Healthcare Inc. (HCA) has been rated Overweight by analysts. According to 0 brokerage firms, HCA is a sell, and 5 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 3 analysts rate HCA Healthcare Inc. stock as buy, with 16 recommending it as overweight.
With a median target price of $323.00, the current consensus forecast for the stock is $275.00 – $350.00. Based on these forecasts, analysts predict HCA Healthcare Inc. (HCA) will achieve an average price target of $320.62.
